Heilongjiang ZBD Pharmaceutical Co., Ltd.

SSE:603567.SS

11.25 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011
Operating Activities:
Net Income 436.393472.74190.88332.76437.504405.844463.402523.2496.659579.767464.053424.816384.612296.064
Depreciation & Amortization 144.063190.439169137.102155.888138.42122.409118.06145.982115.18695.5975.10563.55756.958
Deferred Income Tax 00-78.467-7.958-34.77612.812-43.23627.001-28.175-67.070000
Stock Based Compensation 00000000000000
Change In Working Capital -767.62-886.236-764.029-934.618-629.696-538.563-423.007104.565-671.844-1,114.997-235.348-412.838-327.541-272.464
Accounts Receivables 304.343-891.411107.1852,277.626-548.798-746.155-211.909-128.059-428.383-496.039-305.554-265.51-195.7160
Inventory -850.831282.664-270.891381.018-217.015532.082-117.871241.125-18.63-642.912-12.925-62.04-117.881-119.321
Accounts Payables 0-277.489-521.855-3,585.304170.893-337.302-49.991-35.502-196.65691.0240000
Other Working Capital -221.1320-78.467-7.958-34.77612.812-305.136-136.56-653.214-472.085-222.422-350.798-209.66-153.143
Other Non Cash Items 351.472-234.84177.35630.82191.482215.222204.599107.36745.02996.14862.02887.60133.6224.156
Operating Cash Flow 164.308-457.898-326.793-433.937155.178220.923367.403853.19215.826-323.895386.324174.684154.247104.714
Investing Activities:
Investments In Property Plant And Equipment -189.152-95.138-404.273-448.631-868.649-178.785-419.59-492.424-318.744-69.961-79.853-168.726-233.092-139.773
Acquisitions Net 094.866352.224373500.125-17.409-4.75527.065-6.554000.120
Purchases Of Investments -55.15-67-4-785.178-893.305-82.1-0.90.519-1,009000-32.345-9.417
Sales Maturities Of Investments 20.07620.347293.34441.952260.197-0.1254404.672995.6920443.50
Other Investing Activites 118.204223.35346.636397.5980.8720.1250.13261.50.428-372.586.258-6.6223.0752.429
Investing Cash Flow -106.022176.427283.931-421.26-1,450.886-260.76-433.768-30.488-304.56-449.095-69.595-171.345-238.742-146.761
Financing Activities:
Debt Repayment -85223-44.402-278.119522.114535.886750-30397.7280.293-315550178.3-3.3
Common Stock Issued 000-8.7870-3.13700000000
Common Stock Repurchased 00-29.993003.13700000000
Dividends Paid -324.278-158.28-99.848-143.725-184.268-139.262-232.694-202.261-265.182-248.39-101.301-43.463-25.206-22.293
Other Financing Activities -44.884700.973-1011,219.301102.212-67.8020.6340.6069.7171,524.171-61.30131.0370
Financing Cash Flow -454.162765.692-418.945797.457292.107328.822517.94-229.655142.2341,556.075-416.301509.537154.132-25.593
Other Information:
Effect Of Forex Changes On Cash 0000000-000-00042.047
Net Change In Cash -395.876463.875-461.806-57.74-1,003.6288.985451.575593.05-146.5783.085-99.572512.87569.637-25.593
Cash At End Of Period 1,050.3131,446.189982.3141,444.1211,501.862,505.462,216.4761,764.91,171.8511,318.351535.266634.838121.96352.326